Latest filing published 19 May 2015 for ABIOMED INC, €334k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert Bowen: trading record in brief
Robert Bowen is a declared insider at 2 companies; the most frequent names are Abiomed Inc and Novanta Inc. The record holds 48 filings, for trades running from 18 May 2006 to 15 May 2015.
Both buying and selling appear: 1 purchase, against 21 sales worth €3.4M. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 18 share grants and 7 option exercises. So far in 2015, the count stands at no purchases and 5 sales.
The latest filing, published on 19 May 2015, reports an open-market sale of €334k in Abiomed Inc. The most recent open-market purchase was published on 15 February 2008, 6,841 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Bowen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,637 shares@ US$67.65Common Stock, $.01 par valueSEC:0001179110-15-008099:0
- 585 shares@ US$68.46Common Stock, $.01 par valueSEC:0001179110-15-008099:1
- 18,000 shares0Common Stock, $.01 par valueSEC:0001179110-15-007278:0
- 1,549 shares@ US$71.04Common Stock, $.01 par valueSEC:0001179110-15-007278:1
- 573 shares@ US$72.14Common Stock, $.01 par valueSEC:0001179110-15-007278:2
- 250 shares@ US$73.09Common Stock, $.01 par valueSEC:0001179110-15-007278:3
- 7,740 shares0Common Stock, $.01 par valueSEC:0001179110-14-009404:0
- 2,590 shares@ US$20.96Common Stock, $.01 par valueSEC:0001179110-14-009300:0
- 4,230 shares@ US$21.21Common Stock, $.01 pr valueSEC:0001179110-14-009300:1
- 990 shares@ US$20.94Common Stock, $.01 par valueSEC:0001179110-14-008672:0
- 30,000 shares@ US$5.86Common Stock, $.01 par valueSEC:0001179110-14-000951:0
- 7,500 shares@ US$10.03Common Stock, $.01 par valueSEC:0001179110-14-000951:1
- 37,500 shares@ US$30.00Common Stock, $.01 par valueSEC:0001179110-14-000951:2
- 2,235.33 shares@ US$22.64Common Stock, $.01 par valueSEC:0001179110-13-012839:0
- 40,786 shares@ US$5.86Common Stock, $.01 par valueSEC:0001179110-13-011859:0
- 40,786 shares@ US$23.50Common Stock, $.01 par valueSEC:0001179110-13-011859:1
- 1,499 shares@ US$5.86Common Stock, $.01 par valueSEC:0001179110-13-011773:0
- 1,499 shares@ US$23.50Common Stock, $.01 par valueSEC:0001179110-13-011773:1
- 5,298 shares@ US$21.20Common Stock, $.01 par valueSEC:0001179110-13-009856:0
- 5,102 shares@ US$22.18Common Stock, $.01 par valueSEC:0001179110-13-009366:0
- 9,000 shares0Common Stock, $.01 par valueSEC:0001179110-13-009366:1
- 812 shares@ US$21.60Common Stock, $.01 par valueSEC:0001179110-13-009254:0
- 2,715 shares@ US$5.86Common Stock, $.01 par valueSEC:0001179110-13-008770:0
- 2,715 shares@ US$23.50Common Stock, $.01 par valueSEC:0001179110-13-008770:1
- 7,000 shares0Common Stock, $.01 par valueSEC:0001179110-13-008554:0
25 of 47 declarations
